S. Carl

1.3k total citations
27 papers, 274 citations indexed

About

S. Carl is a scholar working on Transplantation, Surgery and Nephrology. According to data from OpenAlex, S. Carl has authored 27 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Transplantation, 6 papers in Surgery and 6 papers in Nephrology. Recurrent topics in S. Carl's work include Renal Transplantation Outcomes and Treatments (15 papers), Renal Diseases and Glomerulopathies (6 papers) and Organ Transplantation Techniques and Outcomes (4 papers). S. Carl is often cited by papers focused on Renal Transplantation Outcomes and Treatments (15 papers), Renal Diseases and Glomerulopathies (6 papers) and Organ Transplantation Techniques and Outcomes (4 papers). S. Carl collaborates with scholars based in Germany, Croatia and United States. S. Carl's co-authors include M. Wiesel, Gerhard Opelz, G. Staehler, Rolf Weimer, Volker Daniel, Gerd Staehler, J. Dörsam, M.G. Lucas, Arwin Ridder and Christopher R. Chapple and has published in prestigious journals such as The Journal of Urology, Transplantation and Urology.

In The Last Decade

S. Carl

26 papers receiving 256 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Carl Germany 9 114 75 66 55 50 27 274
Tomonosuke Someya Japan 11 19 0.2× 36 0.5× 37 0.6× 32 0.6× 20 0.4× 30 312
Dubernard Jm France 10 92 0.8× 191 2.5× 22 0.3× 32 0.6× 12 0.2× 72 321
Shoichiro Iwatsuki Japan 9 48 0.4× 122 1.6× 15 0.2× 43 0.8× 6 0.1× 41 283
Piotr Szyber Poland 10 51 0.4× 156 2.1× 34 0.5× 2 0.0× 20 0.4× 42 240
David P. Segel United States 8 9 0.1× 55 0.7× 34 0.5× 8 0.1× 11 0.2× 11 349
Kiyohide Sakai Japan 11 6 0.1× 154 2.1× 41 0.6× 116 2.1× 5 0.1× 40 408
Tuula Hölttä Finland 13 24 0.2× 56 0.7× 10 0.2× 2 0.0× 49 1.0× 18 338
Thelma J. Baxter Australia 7 15 0.1× 172 2.3× 19 0.3× 29 0.5× 2 0.0× 16 357
Michael van Husen Germany 8 20 0.2× 38 0.5× 13 0.2× 3 0.1× 102 2.0× 10 363
S. Timothy Spicer Australia 11 39 0.3× 76 1.0× 14 0.2× 1 0.0× 147 2.9× 14 359

Countries citing papers authored by S. Carl

Since Specialization
Citations

This map shows the geographic impact of S. Carl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Carl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Carl more than expected).

Fields of papers citing papers by S. Carl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Carl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Carl. The network helps show where S. Carl may publish in the future.

Co-authorship network of co-authors of S. Carl

This figure shows the co-authorship network connecting the top 25 collaborators of S. Carl. A scholar is included among the top collaborators of S. Carl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Carl. S. Carl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Möhn, Nora, Thomas Skripuletz, S. Carl, et al.. (2025). Complement activation profiles in patients with immune checkpoint inhibitor-associated neuromuscular immune-related adverse events. Journal of Neurology. 272(7). 459–459.
2.
Chapple, Christopher R., Osamu Yamaguchi, Arwin Ridder, et al.. (2008). CLINICAL PROOF OF CONCEPT STUDY (BLOSSOM) SHOWS NOVEL β3 ADRENOCEPTOR AGONIST YM178 IS EFFECTIVE AND WELL TOLERATED IN THE TREATMENT OF SYMPTOMS OF OVERACTIVE BLADDER. European Urology Supplements. 7(3). 239–239. 53 indexed citations
3.
4.
Bose, Anuradha, et al.. (2007). Neonatal gastric perforation following inadvertent connection of oxygen to the nasogastric feeding tube: Figure 1. Archives of Disease in Childhood Fetal & Neonatal. 92(5). F407–F407. 6 indexed citations
5.
Carl, S., et al.. (2007). 901 TREATMENT OF INTERSTITIAL CYSTITIS WITH BOTULINUM TOXIN TYPE A. European Urology Supplements. 6(2). 248–248. 3 indexed citations
6.
Carl, S., et al.. (2000). Kidney splitting in miniature swine: a new animal model in renal transplantation. Transplantation Proceedings. 32(4). 800–801. 2 indexed citations
7.
Daniel, Volker, Anette Melk, Rolf Weimer, et al.. (1999). Predictive indicators of rejection or infection in renal transplant patients. Transplantation Proceedings. 31(1-2). 1364–1365. 8 indexed citations
8.
Carl, S., J. Dörsam, A Mandelbaum, G. Staehler, & M. Wiesel. (1998). Combining FK 506 and Mycophenolate Mofetil for the Treatment of Acute Corticosteroid-Resistant Rejection Following Kidney Transplantation: A New Therapeutic Concept. Transplantation Proceedings. 30(4). 1236–1237. 4 indexed citations
9.
Weimer, Rolf, et al.. (1998). Superior 3-year kidney graft function in patients with impaired pretransplant Th2 responses. Transplant International. 11(7). S350–S356. 8 indexed citations
10.
Carl, S., M. Wiesel, & G. Staehler. (1998). Use of mycophenolate mofetil for prevention of acute rejection in renal transplantation. Der Urologe. 37(3). 282–286. 2 indexed citations
12.
Carl, S.. (1997). Mycophenolate mofetil (Cellcept) inrenal transplantation : the Eurpean experience. Transplantation Proceedings. 29(7). 2932–2953. 2 indexed citations
13.
Süsal, Caner, M. Wiesel, C. Schönemann, et al.. (1997). Presensitization and HLA match influence the predictive power of pretransplant serum IgA and IgA-anti-Fab autoantibodies in kidney graft recipients. Transplantation Proceedings. 29(1-2). 1444–1446. 4 indexed citations
14.
Carl, S., M. Wiesel, Volker Daniel, et al.. (1997). Rescue therapy with interleukin-2 receptor antibody in high risk kidney transplant patients: A 3-year follow-up study. Transplantation Proceedings. 29(1-2). 320–322. 4 indexed citations
15.
Carl, S. & M. Wiesel. (1997). Mycophenolate mofetil (cellcept) in renal transplantation: The European experience. Transplantation Proceedings. 29(7). 2932–2935. 3 indexed citations
16.
Carl, S., et al.. (1997). Outcome of children and adolescents with recurrent nephrotic syndrome and focal segmental glomerulosclerosis after renal transplantation. Transplantation Proceedings. 29(7). 2795–2796. 6 indexed citations
17.
18.
Dörsam, J., Michael V. Knopp, S. Carl, et al.. (1997). Ureteral complications after kidney transplantation—Evaluation with functional magnetic resonance urography. Transplantation Proceedings. 29(1-2). 132–135. 18 indexed citations
19.
Weimer, Rolf, et al.. (1996). PRETRANSPLANT CD4 HELPER FUNCTION AND INTERLEUKIN 10 RESPONSE PREDICT RISK OF ACUTE KIDNEY GRAFT REJECTION1. Transplantation. 62(11). 1606–1614. 47 indexed citations
20.
Carl, S., M. Wiesel, Daniel Daniel, & G. Staehler. (1995). Effect of anti-IL-2-receptor monoclonal antibody BT 563 in treatment of acute interstitial renal rejection.. PubMed. 27(1). 854–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026